Tectonic Therapeutic | AVRO - 営業経費

株価
28.54
毎日の変更
0.10 0.35%
毎月
-8.11%
毎年
35.32%
Q2 予測
27.93




営業経費 変化する 日付
Akebia Therapeutics USD 63.08M 8.26M 2025-12
Alnylam Pharmaceuticals USD 965.32M 84.27M 2025-12
Celltrion KRW 724.99B 6B 2025-09
Cspc Pharmaceutical CNY 5.91B 512.77M 2025-12
Deva Holding AS TRY 1.35B 178.26M 2023-09
Dianthus Therapeutics USD 69.82M 29.14M 2025-12
Divis Laboratories Ltd INR 18.32B 1.08B 2025-12
Gilead Sciences USD 4.96B 707M 2025-12
Ionis Pharmaceuticals USD 418M 101.1M 2025-12
Kangmei Pharma CNY 1.39B 144.29M 2025-09
Karyopharm Therapeutics USD 51.92M 9.9M 2025-12
Knight Therapeutics CAD 126.9M 8.29M 2025-12
Laboratorios Farma EUR 313.62M 17.98M 2023-12
MacroGenics USD 53.32M 13.68M 2025-12
Malin Corporation EUR 1.1M 400K 2024-12
Medical Developments International AUD 21.61M 11.59M 2025-12
Neuren Pharmaceuticals AUD 25.23M 16.54M 2025-12
Organigram Holdings CAD 83.66M 24.44M 2025-12
Ovoca Bio EUR 1.16M 4.48M 2025-06
Pfizer USD 12.91B 79.89B 2025-12
Pharma Mar EUR 46.87M 7.24M 2025-12
Qiagen NV USD 418.54M 23.25M 2025-12
Roche Holding CHF 21.01B 10.84B 2025-12
Sangamo BioSciences USD 33.87M 12.89M 2024-06
Sanofi EUR 9.31B 1.2B 2026-03
Sarepta Therapeutics USD 853.02M 390.78M 2025-12
Sartorius EUR 738.4M 22.4M 2026-03
Sino Biopharmaceutical CNY 12.39B 1.26B 2025-06
Takeda JPY 1.02T 400.98B 2025-12
Tilray USD 237.52M 17.34M 2025-09
Zealand Pharma A/S 775.97M 265.08M 2025-12
Zz Pientze Pharmaceu CNY 1.55B 129.66M 2025-09